Medical Excellence
Medical Affairs has become a strategic pillar — not a support function. WLH partners with medical leaders to define the role of medical affairs and build the capabilities required to deliver strategic impact.
Overview
Medical affairs is now expected to shape strategy, generate insights, and influence decisions across the organization. Many teams are still structured, staffed, and developed for a narrower support role, creating a gap between expectations and execution.
WLH helps pharma and biotech organizations close that gap by defining the role of medical, aligning it to patient and business priorities, and building the capabilities and operating models required to deliver consistently.
Capabilities
Building the capabilities that modern Medical Affairs teams need to succeed
Medical Affairs Transformation
Redefine the role of medical affairs as a strategic function by aligning priorities, structure, and cross-functional ways of working to support scientific engagement and insight generation.
Medical Business Acumen
Build the business and strategic understanding required for medical leaders and teams to operate effectively across commercial and market access while maintaining scientific integrity.
Medical Care Gaps Strategy
Identify and prioritize care gaps where medical can drive meaningful impact by aligning medical strategy, evidence generation, and stakeholder engagement.
Medical Role Design & Optimization
Define roles, responsibilities, and team structures across field and HQ medical to improve clarity, consistency, and effectiveness in execution and cross-functional collaboration.
Challenges We Address
Why Organizations Partner With WLH
Medical Affairs Expected to Lead, but Not Structured To
Organizations expect medical to influence strategy and generate insight, but roles, priorities, and operating models are still aligned to a narrower support function.
Medical and Commercial Operating in Parallel, Not Together
Medical Affairs, Commercial, and Market Access each have customer relationships and strategic objectives, but rarely a coordinated plan. Without aligned engagement at the account level, organizations send mixed messages and miss the compounding value of cross-functional alignment.
Limited Business Acumen Across Medical Teams
Medical teams are asked to engage in cross-functional decision making but often lack the business context needed to influence effectively while maintaining scientific credibility.
No Clear Care Gap Strategy
Define care gap priorities by analyzing how evidence is understood and applied in practice. We help medical organizations determine where deeper exploration is needed in the field and align engagement to the factors that influence real-world clinical decisions.
Our Approach
Execution-Focused by Design
Diagnose
Assess medical strategy, role clarity, and organizational alignment to identify where gaps exist between expectations and execution.
Design
Design medical strategy, role definitions, and operating models aligned to stakeholder needs and business priorities.
Deploy
Implement through leadership alignment, role clarity, and integrated approaches that strengthen consistency across teams.
Measure
Measure impact through engagement quality, insight generation, and cross-functional effectiveness, and refine over time.
Related Learning
Medical Business Acumen
Equips medical teams to engage as credible business and strategic partners.
LENS: Medical Excellence System for Scientific Engagement
An end-to-end system for elevating scientific engagement quality and impact.
Field Leader Bootcamp
Foundational leadership skills for new and aspiring field medical leaders.
Related Insights
Frameworks, articles, and case studies on Medical Excellence.
ARTICLE
A Call to Action: Optimizing Pharmaceutical Field Force Effectiveness and Account Team Collaboration after your National Sales Meeting (NSM)
At the start of the year, many companies pull their teams together for regional or national sales meetings to align them around the new strategy.
ARTICLE
Field Based Monitoring: Best Practices for Pharma Companies
In the past five years, the Department of Justice (DOJ) has levied almost $22 billion in fines against pharmaceutical companies.
CASE STUDY
Upskilling Business Acumen for Medical Outcomes and Science Liaisons (MOSLs)
A pharmaceutical company developed a Curriculum Roadmap to enhance MOSLs’ business acumen for calling on Payer accounts.
Client Voice
WLH's team took time to understand my team — they went above and beyond. We had people opening up and working together in a way that I didn't expect. They began trusting each other more. Most corporate learning sessions I have been involved with in my career don't have that effect.
Veronica Lee
Head of Medical Affairs
Proven Results
Outcomes that compound across the partnership.
Verified across consulting and learning engagements with pharma and biotech leaders.
100
NPS
Across both consulting and learning solutions
5/5
Ratings
Consulting performance across nearly every criterion
8/15
Clients
Reporting increasing demand for WLH going forward
Client Trust
Let’s Talk
Start a Conversation
We work with leadership teams to navigate complex transformation and drive sustained organizational change.